# Haloperidol

NDC: 0615-8355
Generic name: Haloperidol
Labeler / Manufacturer: NCS HealthCare of KY, LLC dba Vangard Labs
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20200109
Marketing ended: 20260531
FDA application: ANDA211061

## Active ingredients

- HALOPERIDOL: 5 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0615-8355"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0615-8355
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e7dcb764-d58d-4476-b981-3bd54f0d896e